Figure 2: Development and noninvasive treatment of bilateral subdural hygromas following placement of a programmable shunt for idiopathic normal pressure hydrocephalus. Although CSF shunting is a ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint ...

As a result, more patients are seeking effective treatments, contributing to increased demand for shunt systems. As the global population ages, the incidence of age-related conditions such as ...

INPH typically occurs in adults more than 60 years old and is ... and urinary incontinence generally responds to treatment if present for less than 2 years' duration. Gait and balance ...

"CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study" was originally created and published by Medical Device Network, a GlobalData owned brand.

Based on these clinical findings, I plan to pursue further research to facilitate the practical application of ultrasound treatment for patients with normal pressure hydrocephalus.” Lee Dong ...

Given the above statistics, it is important for us to cautiously consider stimulant treatment in adults with an eye toward the potential of diversion, misuse and toxicity. It is with the safety of ...

Wireless brain sensor and wand technology could transform hydrocephalus care. While traditional hydrocephalus treatments rely on shunts that can be prone to failure, the need for more reliable, ...

Tamiflu treatment on day of hospital admission was associated with a reduced risk for disease progression among adults hospitalized with influenza. Researchers conducted a study to assess the clinical ...